A Breath of Fresh Air: New Treatment Strategies for Chronic Rhinosinusitis with Nasal Polyps

Format: Webinar
Credit(s): 1.00 (60 min)
Webinar Date(s):
Tuesday, December 6, 2022 5:45 - 6:45 PM CT
Credit Type(s):
  • Physicians – AMA PRA Category 1 Credit(s) ™
  • Physicians – prescribed AAFP Credit(s)
  • Physicians/ABIM MOC – ABIM MOC Point(s)

PROGRAM OVERVIEW

Chronic rhinosinusitis with nasal polyps (CRSwNP) is the most common cause of nasal polyposis, and approximately one third of patients with chronic rhinosinusitis (CRS) will develop nasal polyps. CRSwNP is associated with significant morbidity and negative impacts on patient quality of life, making rapid diagnosis and treatment highly important. Until recently, treatment for CRSwNP has included topical therapy, systemic corticosteroids, and surgery, with minimal efficacy and high morbidity. However, improved understanding of the pathophysiology of CRSwNP has led to the development of numerous biologic therapies that target the inflammatory pathways underlying disease pathogenesis. These agents are more effective and less toxic than historic treatments.

This activity, A Breath of Fresh Air: New Treatment Strategies for Chronic Rhinosinusitis with Nasal Polyps will review the major causes of nasal polyps and how to diagnose CRSwNP, the pathophysiology of CRSwNP, the safety and efficacy of approved treatment options that target the underlying pathophysiology of CRSwNP, and new agents on the horizon.

SUPPORTER

Jointly provided by the Potomac Center for Medical Education and Rockpointe
     

This program is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.

RELATED COURSES

Integrating the FDA Mycophenolate Safety Standards to Prevent Adverse Pregnancy Outcomes

Learn More

Advances in Cancer Screening and Detection: What PCPs Need to Know

Learn More

Advances in Skin Cancer Diagnosis: Using New Technologies to Identify High Risk Patients

Learn More
This entry was posted in . Bookmark the permalink.

Follow Us :

Follow Us :

© 2021 Rockpointe Corporation

Privacy Policy

© 2021 Rockpointe Corporation

Privacy Policy